The Talking PointThe Talking Point

Health Talk: ‘Virginal ring

View descriptionShare
The International Partnership for Microbicides, IPM has welcomed a positive opinion from the European Medicines Agency on a monthly vaginal ring for use by women of ages between eighteen and older in developing countries to reduce their risk of HIV infection. The vaginal ring is the first long-acting HIV prevention product and is designed to help address women's need for new methods given the persistently high rates of HIV they face, especially in sub-Saharan Africa.

GUEST: Dr. Zeda Rosenberg – CEO of the International Partnership for Microbicides (USA)
  • Facebook
  • X (Twitter)
  • WhatsApp
  • Email
  • Download

In 1 playlist(s)

The Talking Point

Newsmakers and Guest Experts offer their insights and perspectives into the national and global disc 
Social links
Recent clips
Browse 7,233 clip(s)